South African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and '4-in-1' fixed-dose combination...

The move gains significance as global drug makers involved in the development of Covid therapeutics have refused to give up patents over th...

Leena Menghaney, a lawyer with MSF India, told ET that it is critical for governments to address this global crisis as they did nearly 20 y...

Pharmaceutical companies and researchers must urgently focus on new antibiotics against certain types of extremely serious infections, said...

It involves collaboration between 25 under-graduate and Master's students in Chemistry from participating universities.

Cipla today said an anti-malarial drug developed by Drugs for Neglected Diseases initiative (DNDi) has received pre-qualification from WHO.

Cipla will work to produce an appropriate 4-in-1 combination sachet product for easy mixing into food or liquids such as water, juice, or b...

Less than 10% of the $160 bn R&D spend is devoted to 90% of the world’s disease burden. India suffers, yet it is not being vocal for a glob...

DNDi is a not-for-profit research and development organisation working to deliver new treatments for neglected diseases.

Philanthropic organisations like Gates Foundation are beginning to greatly influence public policy-making.

Many of the world's richest men & women built their business fortunes through disruptive innovations in the for-profit sector. Now, they ar...

After a decade of extraordinary and entrepreneurial wealth creation, it is now time for India Inc to face the hard question: is it giving b...